相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Association Between Dietary Nutrient Composition and the Incidence of Cirrhosis or Liver Cancer in the United States Population
George N. Ioannou et al.
HEPATOLOGY (2009)
Non-alcoholic steatohepatitis and animal models: Understanding the human disease
Marta Varela-Rey et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Acid Sphingomyelinase Deficiency Prevents Diet-induced Hepatic Triacylglycerol Accumulation and Hyperglycemia in Mice
Gergana M. Deevska et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Inhibition of stearoyl-coenzyme A desaturase 1 dissociates insulin resistance and obesity from atherosclerosis
J. Mark Brown et al.
CIRCULATION (2008)
Targeted depletion of hepatic ACAT2-driven cholesterol esterification reveals a non-biliary route for fecal neutral sterol loss
J. Mark Brown et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Impact of non-alcoholic fatty liver disease on accelerated metabolic complications
Jian Gao Fan
JOURNAL OF DIGESTIVE DISEASES (2008)
Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis
Fabio Marra et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Nonalcoholic fatty liver disease: An overview of current insights in pathogenesis, diagnosis and treatment
Tim C. M. A. Schreuder et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: Present and future
Anna Wieckowska et al.
HEPATOLOGY (2007)
Dietary fat-induced alterations in atherosclerosis are abolished by ACAT2-deficiency in ApoB100 only, LDLr-/- mice
Thomas A. Bell et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Liver-specific inhibition of acyl-coenzyme A:cholesterol acyltransferase 2 with antisense oligonucleotides limits atherosclerosis development in apolipoprotein B100-only low-density lipoprotein receptor-/- mice
Thomas A. Bell et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Treatment of non-alcoholic fatty liver disease
LA Adams et al.
POSTGRADUATE MEDICAL JOURNAL (2006)
Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: Possible role in steatosis
MW Bradbury
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Mutation of F417 but not of L418 or L420 in the lipid binding domain decreases the activity of triacylglycerol hydrolase
M Alam et al.
JOURNAL OF LIPID RESEARCH (2006)
Intestinal cholesterol absorption is substantially reduced in mice deficient in both ABCA1 and ACAT2
RE Temel et al.
JOURNAL OF LIPID RESEARCH (2005)
The natural history of nonalcoholic fatty liver disease: A population-based cohort study
LA Adams et al.
GASTROENTEROLOGY (2005)
ACAT2 contributes cholesteryl esters to newly secreted VLDL, whereas LCAT adds cholesteryl ester to LDL in mice
RG Lee et al.
JOURNAL OF LIPID RESEARCH (2005)
Molecular mediators of hepatic steatosis and liver injury
JD Browning et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme A:: Cholesterol acyltransferase 2 have opposite atherosclerotic potential
RG Lee et al.
CIRCULATION RESEARCH (2004)
Triacylglycerol hydrolase: role in intracellular lipid metabolism
VW Dolinsky et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
ACAT2 is localized to Hepatocytes and is the major cholesterol-esterifying enzyme in human liver
P Parini et al.
CIRCULATION (2004)
Deficiency of acyl CoA:cholesterol acyltransferase 2 prevents atherosclerosis in apolipoprotein E-deficient mice
EL Willner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Primates highly responsive to dietary cholesterol up-regulate hepatic ACAT2, and less responsive primates do not
LL Rudel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)